Ivivi gets Nasdaq deficiency notice

Ivivi Technologies (Montvale, New Jersey), a maker of non-invasive electrotherapy systems, said it received a deficiency notice from the staff of the Nasdaq that the company does not comply with Nasdaq Marketplace Rule 4310(c)(3), which requires the company to have a minimum of $2,500,000 in stockholders' equity or $35,000,000 market value of listed securities or $500,000 of net income from continuing operations for the most recently completed fiscal year or two of the three most recently completed fiscal years.

The Nasdaq staff is reviewing the company's eligibility for continued listing on the Nasdaq Capital Market.

No Comments